Zim Laboratories Ltd

About [ edit ]

Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India.

  • Market Cap 122 Cr.
  • Current Price 75.0
  • High / Low 131 / 55.0
  • Stock P/E 12.1
  • Book Value 95.1
  • Dividend Yield 0.00 %
  • ROCE 4.75 %
  • ROE 1.16 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.79 times its book value

Cons

  • Promoter holding is low: 33.26%
  • Company has a low return on equity of 7.64% for last 3 years.
  • Dividend payout has been low at 3.15% of profits over last 3 years
  • Company's cost of borrowing seems high
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
70.63 69.91 71.14 97.05 93.63 66.86 67.34 72.19 67.93 69.77 86.45 74.23
62.37 62.18 61.11 84.67 81.34 64.16 62.94 65.33 62.12 60.04 75.28 66.85
Operating Profit 8.26 7.73 10.03 12.38 12.29 2.70 4.40 6.86 5.81 9.73 11.17 7.38
OPM % 11.69% 11.06% 14.10% 12.76% 13.13% 4.04% 6.53% 9.50% 8.55% 13.95% 12.92% 9.94%
Other Income 7.44 0.34 0.19 0.72 0.80 1.12 0.44 0.65 2.45 0.64 -5.01 0.79
Interest 2.94 2.63 2.97 2.51 2.48 3.24 3.17 3.23 3.01 2.94 2.67 2.34
Depreciation 2.61 2.59 2.85 2.76 2.95 3.08 3.16 3.47 3.56 3.55 3.54 3.62
Profit before tax 10.15 2.85 4.40 7.83 7.66 -2.50 -1.49 0.81 1.69 3.88 -0.05 2.21
Tax % 31.53% 5.61% 30.91% 27.84% 39.56% 100.80% 67.79% 14.81% 10.06% 28.61% -20.00% 31.22%
Net Profit 6.95 2.69 3.05 5.65 4.62 0.03 -0.49 0.69 1.51 2.77 -0.06 1.53
EPS in Rs 1.67 1.89 3.51 2.87 0.02 -0.30 0.43 0.93 1.71 -0.04 0.94

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
268 235 272 332 274 298
238 203 238 289 255 264
Operating Profit 30 32 34 43 20 34
OPM % 11% 14% 12% 13% 7% 11%
Other Income -2 5 9 2 5 -1
Interest 14 10 9 11 13 11
Depreciation 9 9 10 11 13 14
Profit before tax 5 18 24 23 -1 8
Tax % 5% -6% 24% 30% 216%
Net Profit 5 19 18 16 2 6
EPS in Rs 9.93 1.08 3.54
Dividend Payout % 16% 4% 4% 5% 0%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:5%
TTM:-1%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:-55%
TTM:108%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:2%
Return on Equity
10 Years:%
5 Years:%
3 Years:8%
Last Year:1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
8 8 8 16 16 16
Reserves 91 110 128 135 136 138
Borrowings 96 81 81 77 90 65
61 60 80 96 81 103
Total Liabilities 256 259 297 325 323 322
92 89 94 101 111 111
CWIP 3 4 8 13 10 5
Investments 0 0 0 5 8 8
161 166 195 206 194 198
Total Assets 256 259 297 325 323 322

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
22 32 37 37 21
-12 -7 -26 -23 -18
-10 -25 -10 -15 -3
Net Cash Flow -0 -0 1 -1 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 14% 13% 15% 5%
Debtor Days 120 137 119 99 84
Inventory Turnover 3.42 3.37 3.13 2.70

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
33.52 33.52 33.52 33.52 33.39 33.39 33.39 33.39 33.39 33.26 33.26
66.48 66.48 66.48 66.48 66.61 66.61 66.61 66.61 66.61 66.74 66.74

Documents